-
1
-
-
77649147753
-
Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation
-
Tang WH, Wu Y, Nicholls SJ, Brennan DM, Pepoy M, Mann S, et al. Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation. Arterioscler Thromb Vasc Biol 2010;30:634-40.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 634-640
-
-
Tang, W.H.1
Wu, Y.2
Nicholls, S.J.3
Brennan, D.M.4
Pepoy, M.5
Mann, S.6
-
2
-
-
0033552883
-
Atherosclerosis: An inflammatory disease
-
Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
3
-
-
0037469177
-
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
-
DOI 10.1161/01.CIR.0000053730.47739.3C
-
Ridker PM. Clinical applications of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. (Pubitemid 36158034)
-
(2003)
Circulation
, vol.107
, Issue.3
, pp. 363-369
-
-
Ridker, P.M.1
-
4
-
-
33644674993
-
Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself
-
Pepys MB, Hawkins PN, Kahan MC, Tennent GA, Gallimore JR, Graham D, et al. Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res 2005;97:e97-103.
-
(2005)
Circ Res
, vol.97
-
-
Pepys, M.B.1
Hawkins, P.N.2
Kahan, M.C.3
Tennent, G.A.4
Gallimore, J.R.5
Graham, D.6
-
5
-
-
67649961412
-
Genetic loci associated with C-reactive protein levels and risk of coronary heart disease
-
Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009;302:37-48.
-
(2009)
JAMA
, vol.302
, pp. 37-48
-
-
Elliott, P.1
Chambers, J.C.2
Zhang, W.3
Clarke, R.4
Hopewell, J.C.5
Peden, J.F.6
-
7
-
-
0034534961
-
Nitric oxide is a physiological substrate for mammalian peroxidases
-
DOI 10.1074/jbc.275.48.37524
-
Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 2000;275:37524-32. (Pubitemid 32004861)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.48
, pp. 37524-37532
-
-
Abu-Soud, H.M.1
Hazen, S.L.2
-
8
-
-
0037189377
-
Myeloperoxidase, a leukocyte-derived vascular NO oxidase
-
DOI 10.1126/science.1106830
-
Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (Wash DC) 2002;296:2391-4. (Pubitemid 34734213)
-
(2002)
Science
, vol.296
, Issue.5577
, pp. 2391-2394
-
-
Eiserich, J.P.1
Baldus, S.2
Brennan, M.-L.3
Ma, W.4
Zhang, C.5
Tousson, A.6
Castro, L.7
Lusis, A.J.8
Nauseef, W.M.9
White, C.R.10
Freeman, B.A.11
-
9
-
-
0032739169
-
Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo
-
Hazen SL, Zhang R, Shen Z, Wu W, Podrez EA, MacPherson JC, et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res 1999;85:950-8. (Pubitemid 29534170)
-
(1999)
Circulation Research
, vol.85
, Issue.10
, pp. 950-958
-
-
Hazen, S.L.1
Zhang, R.2
Shen, Z.3
Wu, W.4
Podrez, E.A.5
MacPherson, J.C.6
Schmitt, D.7
Mitra, S.N.8
Mukhopadhyay, C.9
Chen, Y.10
Cohen, P.A.11
Hoff, H.F.12
Abu-Soud, H.M.13
-
10
-
-
0035798684
-
Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase
-
Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001;276:41279-87.
-
(2001)
J Biol Chem
, vol.276
, pp. 41279-41287
-
-
Fu, X.1
Kassim, S.Y.2
Parks, W.C.3
Heinecke, J.W.4
-
11
-
-
3042812429
-
Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis
-
DOI 10.1161/01.ATV.0000131784.50633.4f
-
Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 2004;24:1309-14. (Pubitemid 38880026)
-
(2004)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.24
, Issue.7
, pp. 1309-1314
-
-
Sugiyama, S.1
Kugiyama, K.2
Aikawa, M.3
Nakamura, S.4
Ogawa, H.5
Libby, P.6
-
12
-
-
4344577056
-
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and function impairment in subjects with cardiovascular disease
-
DOI 10.1172/JCI200421109
-
Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004;114:529-41. (Pubitemid 39572103)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.4
, pp. 529-541
-
-
Zheng, L.1
Nukuna, B.2
Brennan, M.-L.3
Sun, M.4
Goormastic, M.5
Settle, M.6
Schmitt, D.7
Fu, X.8
Thomson, L.9
Fox, P.L.10
Ischiropoulos, H.11
Smith, J.D.12
Kinter, M.13
Hazen, S.L.14
-
13
-
-
4444292600
-
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport
-
DOI 10.1073/pnas.0405292101
-
Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 2004;101:13032-7. (Pubitemid 39167578)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.35
, pp. 13032-13037
-
-
Bergt, C.1
Pennathur, S.2
Fu, X.3
Byun, J.4
O'Brien, K.5
McDonald, T.O.6
Singh, P.7
Anantharamaiah, G.M.8
Chait, A.9
Brunzell, J.10
Geary, R.L.11
Oram, J.F.12
Heinecke, J.W.13
-
14
-
-
71449125360
-
Modification of high density lipoprotein by myeloperoxidase generates a proinflammatory particle
-
Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL. Modification of high density lipoprotein by myeloperoxidase generates a proinflammatory particle. J Biol Chem 2009;284:30825-35.
-
(2009)
J Biol Chem
, vol.284
, pp. 30825-30835
-
-
Undurti, A.1
Huang, Y.2
Lupica, J.A.3
Smith, J.D.4
DiDonato, J.A.5
Hazen, S.L.6
-
15
-
-
0033672930
-
Consequences of total and subtotal myeloperoxidase deficiency: Risk or benefit?
-
Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ? Acta Haematol 2000;104:10-5.
-
(2000)
Acta Haematol
, vol.104
, pp. 10-15
-
-
Kutter, D.1
Devaquet, P.2
Vanderstocken, G.3
Paulus, J.M.4
Marchal, V.5
Gothot, A.6
-
16
-
-
0034904840
-
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians
-
DOI 10.1067/mhj.2001.116769
-
Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001;142:336-9. (Pubitemid 32706293)
-
(2001)
American Heart Journal
, vol.142
, Issue.2
, pp. 336-339
-
-
Nikpoor, B.1
Turecki, G.2
Fournier, C.3
Theroux, P.4
Rouleau, G.A.5
-
17
-
-
0037406516
-
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients
-
Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Barany P, Hoff CM, et al. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl 2003:S172-6. (Pubitemid 36513403)
-
(2003)
Kidney International, Supplement
, vol.63
, Issue.84
-
-
Pecoits-Filho, R.1
Stenvinkel, P.2
Marchlewska, A.3
Heimburger, O.4
Barany, P.5
Hoff, C.M.6
Holmes, C.J.7
Suliman, M.8
Lindholm, B.9
Schalling, M.10
Nordfors, L.11
-
18
-
-
1642580611
-
Prognostic value of myeloperoxidase in patients with chest pain
-
author reply 8
-
Asselbergs FW, Tervaert JW, Tio RA. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2004;350:516-8; author reply 8.
-
(2004)
N Engl J Med
, vol.350
, pp. 516-518
-
-
Asselbergs, F.W.1
Tervaert, J.W.2
Tio, R.A.3
-
19
-
-
1542314886
-
Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease [1]
-
DOI 10.1016/j.amjmed.2003.10.025, PII S0002934303006910
-
Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA, Tio RA. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med 2004;116:429-30. (Pubitemid 38299491)
-
(2004)
American Journal of Medicine
, vol.116
, Issue.6
, pp. 429-430
-
-
Asselbergs, F.W.1
Reynolds, W.F.2
Cohen-Tervaert, J.W.3
Jessurun, G.A.J.4
Tio, R.A.5
-
20
-
-
70350620976
-
A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function
-
Rudolph V, Rudolph TK, Kubala L, Clauberg N, Maas R, Pekarova M, et al. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function. Free Radic Biol Med 2009;47:1584-90.
-
(2009)
Free Radic Biol Med
, vol.47
, pp. 1584-1590
-
-
Rudolph, V.1
Rudolph, T.K.2
Kubala, L.3
Clauberg, N.4
Maas, R.5
Pekarova, M.6
-
21
-
-
33746081712
-
Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males
-
DOI 10.1194/jlr.M600005-JLR200
-
Castellani LW, Chang JJ, Wang X, Lusis AJ, Reynolds WF. Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males. J Lipid Res 2006;47:1366-77. (Pubitemid 44079890)
-
(2006)
Journal of Lipid Research
, vol.47
, Issue.7
, pp. 1366-1377
-
-
Castellani, L.W.1
Chang, J.J.2
Wang, X.3
Lusis, A.J.4
Reynolds, W.F.5
-
22
-
-
20344391164
-
Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice
-
DOI 10.1161/CIRCULATIONAHA.104.516278
-
McMillen TS, Heinecke JW, LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 2005;111:2798-804. (Pubitemid 40791552)
-
(2005)
Circulation
, vol.111
, Issue.21
, pp. 2798-2804
-
-
McMillen, T.S.1
Heinecke, J.W.2
LeBoeuf, R.C.3
-
23
-
-
34948834705
-
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
-
Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007.
-
(2007)
Nat Med
-
-
Wang, Z.1
Nicholls, S.J.2
Rodriguez, E.R.3
Kummu, O.4
Horkko, S.5
Barnard, J.6
-
24
-
-
34347225913
-
Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals. The EPIC-Norfolk Prospective Population Study
-
DOI 10.1016/j.jacc.2007.03.033, PII S0735109707013460
-
Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159-65. (Pubitemid 47002189)
-
(2007)
Journal of the American College of Cardiology
, vol.50
, Issue.2
, pp. 159-165
-
-
Meuwese, M.C.1
Stroes, E.S.G.2
Hazen, S.L.3
Van Miert, J.N.4
Kuivenhoven, J.A.5
Schaub, R.G.6
Wareham, N.J.7
Luben, R.8
Kastelein, J.J.P.9
Khaw, K.-T.10
Boekholdt, S.M.11
-
25
-
-
38449115330
-
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes
-
DOI 10.1111/j.1365-2362.2007.01908.x
-
Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Schomig A, Kastrati A. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 2008;38:90-6. (Pubitemid 351143413)
-
(2008)
European Journal of Clinical Investigation
, vol.38
, Issue.2
, pp. 90-96
-
-
Ndrepepa, G.1
Braun, S.2
Mehilli, J.3
Von Beckerath, N.4
Schomig, A.5
Kastrati, A.6
-
26
-
-
70249144887
-
Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events
-
Wong ND, Gransar H, Narula J, Shaw L, Moon JH, Miranda-Peats R, et al. Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. JACC Cardiovasc Imaging 2009;2:1093-9.
-
(2009)
JACC Cardiovasc Imaging
, vol.2
, pp. 1093-1099
-
-
Wong, N.D.1
Gransar, H.2
Narula, J.3
Shaw, L.4
Moon, J.H.5
Miranda-Peats, R.6
-
27
-
-
34247624608
-
Usefulness of Baseline Plasma Myeloperoxidase Levels as an Independent Predictor of Myocardial Infarction at Two Years in Patients Presenting With Acute Coronary Syndrome
-
DOI 10.1016/j.amjcard.2006.12.060, PII S0002914907002524
-
Cavusoglu E, Ruwende C, Eng C, Chopra V, Yanamadala S, Clark LT, et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 2007;99:1364-8. (Pubitemid 46686633)
-
(2007)
American Journal of Cardiology
, vol.99
, Issue.10
, pp. 1364-1368
-
-
Cavusoglu, E.1
Ruwende, C.2
Eng, C.3
Chopra, V.4
Yanamadala, S.5
Clark, L.T.6
Pinsky, D.J.7
Marmur, J.D.8
-
28
-
-
0141727730
-
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes
-
DOI 10.1161/01.CIR.0000090690.67322.51
-
Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-5. (Pubitemid 37176448)
-
(2003)
Circulation
, vol.108
, Issue.12
, pp. 1440-1445
-
-
Baldus, S.1
Heeschen, C.2
Meinertz, T.3
Zeiher, A.M.4
Eiserich, J.P.5
Munzel, T.6
Simoons, M.L.7
Hamm, C.W.8
-
29
-
-
45349099743
-
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: Myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
-
DOI 10.1093/eurheartj/ehn071
-
Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, Ruff CT, et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 2008;29:1096-102. (Pubitemid 351844877)
-
(2008)
European Heart Journal
, vol.29
, Issue.9
, pp. 1096-1102
-
-
Morrow, D.A.1
Sabatine, M.S.2
Brennan, M.-L.3
De Lemos, J.A.4
Murphy, S.A.5
Ruff, C.T.6
Rifai, N.7
Cannon, C.P.8
Hazen, S.L.9
-
30
-
-
0142089171
-
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
-
DOI 10.1056/NEJMoa035003
-
Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-604. (Pubitemid 37288567)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.17
, pp. 1595-1604
-
-
Brennan, M.-L.1
Penn, M.S.2
Van Lente, F.3
Nambi, V.4
Shishehbor, M.H.5
Aviles, R.J.6
Goormastic, M.7
Pepoy, M.L.8
McErlean, E.S.9
Topol, E.J.10
Nissen, S.E.11
Hazen, S.L.12
-
31
-
-
3042756855
-
Serum myeloperoxidase levels independently predict endothelial dysfunction in humans
-
DOI 10.1161/01.CIR.0000140262.20831.8F
-
Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004;110:1134-9. (Pubitemid 39319014)
-
(2004)
Circulation
, vol.110
, Issue.9
, pp. 1134-1139
-
-
Vita, J.A.1
Brennan, M.-L.2
Gokce, N.3
Mann, S.A.4
Goormastic, M.5
Shishehbor, M.H.6
Penn, M.S.7
Keaney Jr., J.F.8
Hazen, S.L.9
-
32
-
-
84944363874
-
Evaluating the yield of medical tests
-
DOI 10.1001/jama.247.18.2543
-
Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982;247:2543-6. (Pubitemid 12155954)
-
(1982)
Journal of the American Medical Association
, vol.247
, Issue.18
, pp. 2543-2546
-
-
Harrell Jr., F.E.1
Califf, R.M.2
Pryor, D.B.3
-
33
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
-
discussion 207-12
-
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157-72, 2008; discussion 207-12.
-
(2008)
Stat Med
, vol.27
, pp. 157-172
-
-
Pencina, M.J.1
D'Agostino Sr., R.B.2
D'Agostino Jr., R.B.3
Vasan, R.S.4
-
34
-
-
79956133197
-
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations
-
Apple FS, Smith SW, Pearce LA, Schulz KM, Ler R, Murakami MM. Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations. Clin Chem 2011;57:603-8.
-
(2011)
Clin Chem
, vol.57
, pp. 603-608
-
-
Apple, F.S.1
Smith, S.W.2
Pearce, L.A.3
Schulz, K.M.4
Ler, R.5
Murakami, M.M.6
-
35
-
-
67349168178
-
Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction
-
Goldmann BU, Rudolph V, Rudolph TK, Holle AK, Hillebrandt M, Meinertz T, Baldus S. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. Free Radic Biol Med 2009;47:79-83.
-
(2009)
Free Radic Biol Med
, vol.47
, pp. 79-83
-
-
Goldmann, B.U.1
Rudolph, V.2
Rudolph, T.K.3
Holle, A.K.4
Hillebrandt, M.5
Meinertz, T.6
Baldus, S.7
-
36
-
-
74249085403
-
Myeloperoxidase is not useful for the early assessment of patients with chest pain
-
Eggers KM, Dellborg M, Johnston N, Oldgren J, Swahn E, Venge P, Lindahl B. Myeloperoxidase is not useful for the early assessment of patients with chest pain. Clin Biochem 2010;43:240-5.
-
(2010)
Clin Biochem
, vol.43
, pp. 240-245
-
-
Eggers, K.M.1
Dellborg, M.2
Johnston, N.3
Oldgren, J.4
Swahn, E.5
Venge, P.6
Lindahl, B.7
-
37
-
-
73249146667
-
Serial analyses of C-reactive protein and myeloperoxidase in acute coronary syndrome
-
Borges FK, Stella SF, Souza JF, Wendland AE, Werres Junior LC, Ribeiro JP, Polanczyk CA. Serial analyses of C-reactive protein and myeloperoxidase in acute coronary syndrome. Clin Cardiol 2009;32:E58-62.
-
(2009)
Clin Cardiol
, vol.32
-
-
Borges, F.K.1
Stella, S.F.2
Souza, J.F.3
Wendland, A.E.4
Werres Junior, L.C.5
Ribeiro, J.P.6
Polanczyk, C.A.7
-
38
-
-
58149457256
-
Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain
-
McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol 2009;103:22-8.
-
(2009)
Am J Cardiol
, vol.103
, pp. 22-28
-
-
McCann, C.J.1
Glover, B.M.2
Menown, I.B.3
Moore, M.J.4
McEneny, J.5
Owens, C.G.6
-
39
-
-
0001645466
-
A peroxidase-mediated antimicrobial system in leukocytes
-
Klebanoff SJ. A peroxidase-mediated antimicrobial system in leukocytes. J Clin Invest 1967;46:1078-85.
-
(1967)
J Clin Invest
, vol.46
, pp. 1078-1085
-
-
Klebanoff, S.J.1
|